Mount Vernon Associates’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Mount Vernon Associates's LLY Position: Q3 2026 in Review
Mount Vernon Associates held its Eli Lilly (LLY) position steady in Q3 2026 at 920 shares worth $1.06M. The position accounts for 0.71% of the portfolio, ranked #32.
Mount Vernon Associates first reported a position in LLY in Q4 2018 and has held it in 31 quarters since. The position peaked at $1.1M in Q2 2026. 4,628 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Mount Vernon Associates held 920 shares of Eli Lilly worth $1.06M as of Q3 2026.
- Mount Vernon Associates left its Eli Lilly share count unchanged in Q3 2026.
- Eli Lilly made up 0.71% of Mount Vernon Associates's portfolio in Q3 2026, its #32 holding.
- Mount Vernon Associates first reported a position in Eli Lilly in Q4 2018 and has held it in 31 quarters since.
- Mount Vernon Associates's Eli Lilly position peaked at $1.1M in Q2 2026.
- 4,628 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Mount Vernon Associates's 13F filing for Q3 2026, filed 26 Oct 2026.